Case number 2023-1334
Novartis Pharma AG v. Regeneron Pharmaceuticals, Inc. > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Aug 10, 2023 | 33 | MODIFIED ENTRY: CORRECTED CONFIDENTIAL RESPONSE BRIEF FILED by Appellee Regeneron Pharmaceuticals, Inc.. Service: 08/10/2023 by email. [942192]--[Edited 08/18/2023 by KMH - compliance review complete] [Anish Desai] [Entered: 08/10/2023 07:21 PM] (0) |
| Aug 10, 2023 | 32 | MODIFIED ENTRY: CORRECTED RESPONSE BRIEF FILED by Appellee Regeneron Pharmaceuticals, Inc.. Service: 08/10/2023 by email. [942190] --[Edited 08/18/2023 by KMH - compliance review complete] [Anish Desai] [Entered: 08/10/2023 07:20 PM] (80) |
| Aug 9, 2023 | 31 | NOTICE OF NON-COMPLIANCE: The submission of Appellee Regeneron Pharmaceuticals, Inc., Response Brief [27], [28], is not in compliance with the rules of this court (see attached). Compliant document due on 08/16/2023. Service as of this date by the Clerk of Court. [941817] [KMH] [Entered: 08/09/2023 03:12 PM] (2) |
| Aug 8, 2023 | 30 | **TEXT ONLY** ORDER granting motion to extend time to file brief [29] filed by Appellants Novartis Pharma AG, Novartis Pharmaceuticals Corporation and Novartis Technology LLC. The reply brief is due 10/02/2023. Service as of this date by the Clerk of Court. This order has been issued without an attached document and is official and binding. [941474] [JPS] [Entered: 08/08/2023 02:52 PM] (0) |
| Aug 7, 2023 | 29 | MOTION of Appellants Novartis Pharma AG, Novartis Pharmaceuticals Corporation and Novartis Technology LLC to extend the time to 10/02/2023 to file brief. Service: 08/07/2023 by email. [941212] [23-1334] [William Jay] [Entered: 08/07/2023 05:39 PM] (8) |
| Jul 26, 2023 | 28 | CONFIDENTIAL RESPONSE BRIEF FILED by Appellee Regeneron Pharmaceuticals, Inc.. Service: 07/26/2023 by email. [938727] [23-1334] This document is non-compliant. See Doc No. [31] [Anish Desai] [Entered: 07/26/2023 06:05 PM] (0) |
| Jul 26, 2023 | 27 | RESPONSE BRIEF FILED by Appellee Regeneron Pharmaceuticals, Inc.. Service: 07/26/2023 by email. (PENDING COMPLIANCE REVIEW) [938726] [23-1334] [Anish Desai] [Entered: 07/26/2023 06:02 PM] (221) |
| Jul 25, 2023 | 26 | MODIFIED ENTRY: CORRECTED CONFIDENTIAL OPENING BRIEF FILED by Appellants Novartis Pharma AG, Novartis Pharmaceuticals Corporation and Novartis Technology LLC. Service: 07/25/2023 by email. [938443]--[Edited 08/02/2023 by KMH - compliance review complete] [William Jay] [Entered: 07/25/2023 05:06 PM] (0) |
| Jul 25, 2023 | 25 | MODIFIED ENTRY: CORRECTED OPENING BRIEF FILED by Appellants Novartis Pharma AG, Novartis Pharmaceuticals Corporation and Novartis Technology LLC. Service: 07/25/2023 by email. [938439] --[Edited 08/02/2023 by KMH - compliance review complete] [William Jay] [Entered: 07/25/2023 05:02 PM] (227) |
| Jul 25, 2023 | 24 | ORDER filed granting motion to waive confidentiality requirements [21], but ECF Nos. 20 and 22 are not accepted for filing. Corrected versions of the opening brief, addressing the issues raised above, are due no later than 7 days from the date of entry of this order. (Per Curiam). Service as of this date by the Clerk of Court. [938366] [LMS] [Entered: 07/25/2023 02:15 PM] (2) |
| Jul 13, 2023 | 23 | RESPONSE of Appellee Regeneron Pharmaceuticals, Inc. to Doc No. [21]. Service: 07/13/2023 by email. [936079] [23-1334] [Anish Desai] [Entered: 07/13/2023 12:40 PM] (15) |
| Jul 3, 2023 | 22 | CORRECTED CONFIDENTIAL OPENING BRIEF FILED by Appellants Novartis Pharma AG, Novartis Pharmaceuticals Corporation and Novartis Technology LLC. Service: 07/03/2023 by email. [933874] [23-1334] This doument is non-compliant. See Order [24] [William Jay] [Entered: 07/03/2023 03:39 PM] (0) |
| Jul 3, 2023 | 21 | MOTION of Appellants Novartis Pharma AG, Novartis Pharmaceuticals Corporation and Novartis Technology LLC to waive confidentiality requirements. Service: 07/03/2023 by email. [933872] [23-1334] [William Jay] [Entered: 07/03/2023 03:35 PM] (40) |
| Jul 3, 2023 | 20 | CORRECTED OPENING BRIEF FILED by Appellants Novartis Pharma AG, Novartis Pharmaceuticals Corporation and Novartis Technology LLC. Service: 07/03/2023 by email. [933865] [23-1334] This document is non-compliant. See Order [24] [William Jay] [Entered: 07/03/2023 03:26 PM] (227) |
| Jul 3, 2023 | 19 | Amended Certificate of Interest for Appellants Novartis Pharma AG, Novartis Pharmaceuticals Corporation and Novartis Technology LLC. Service: 07/03/2023 by email. [933857] [23-1334] [William Jay] [Entered: 07/03/2023 03:17 PM] (3) |
| Jun 29, 2023 | 18 | Entry of Appearance for Joshua Weinger as counsel for Appellants Novartis Pharma AG, Novartis Pharmaceuticals Corporation and Novartis Technology LLC. Service: 06/29/2023 by email. [933101] [23-1334] [Joshua Weinger] [Entered: 06/29/2023 10:29 AM] (1) |
| Jun 21, 2023 | 17 | ORDER filed denying [13] the motion to waive the requirements of Federal Circuit Rule 25.1(d)(1) without prejudice to appellants filing a corrected brief or a new motion within 10 days of the date of filing of this order. (see order for further details). Service as of this date by the Clerk of Court. [931353] [LMS] [Entered: 06/21/2023 12:39 PM] (3) |
| Jun 2, 2023 | 16 | ORDER granting motion to extend time to file brief [15] filed by Appellee Regeneron Pharmaceuticals, Inc. The response brief is due 07/26/2023. Service as of this date by the Clerk of Court. [927455] [LMS] [Entered: 06/02/2023 02:28 PM] (2) |
| May 24, 2023 | 15 | MOTION of Appellee Regeneron Pharmaceuticals, Inc. to extend the time to 07/26/2023 to file brief. Service: 05/24/2023 by email. [925734] [23-1334] [Anish Desai] [Entered: 05/24/2023 05:10 PM] (10) |
| May 17, 2023 | 14 | CONFIDENTIAL OPENING BRIEF FILED by Appellants Novartis Pharma AG, Novartis Pharmaceuticals Corporation and Novartis Technology LLC. Service: 05/17/2023 by email. (PENDING COMPLIANCE REVIEW) [924232] [23-1334] [William Jay] [Entered: 05/17/2023 11:55 PM] (0) |
| May 17, 2023 | 13 | MOTION of Appellants Novartis Pharma AG, Novartis Pharmaceuticals Corporation and Novartis Technology LLC to waive confidentiality requirements. Service: 05/17/2023 by email. [924231] [23-1334] [William Jay] [Entered: 05/17/2023 11:52 PM] (32) |
| May 17, 2023 | 12 | OPENING BRIEF FILED by Appellants Novartis Pharma AG, Novartis Pharmaceuticals Corporation and Novartis Technology LLC. Service: 05/17/2023 by email. (PENDING COMPLIANCE REVIEW) [924230] [23-1334] [William Jay] [Entered: 05/17/2023 11:26 PM] (227) |
| May 17, 2023 | 11 | Notice of Related Case Information for Appellants Novartis Pharma AG, Novartis Technology LLC and Novartis Pharmaceuticals Corporation. Service: 05/17/2023 by email. [924123] [23-1334] [William Jay] [Entered: 05/17/2023 02:02 PM] (3) |
| Apr 3, 2023 | 10 | **TEXT ONLY** ORDER granting motion to extend time to file brief [9] filed by Appellants Novartis Pharma AG, Novartis Pharmaceuticals Corporation and Novartis Technology LLC. The opening brief is due 05/17/2023. Service as of this date by the Clerk of Court. This order has been issued without an attached document and is official and binding. [914074] [KMH] [Entered: 04/03/2023 03:29 PM] (0) |
| Mar 29, 2023 | 9 | MOTION of Appellants Novartis Pharma AG, Novartis Pharmaceuticals Corporation and Novartis Technology LLC to extend the time to 05/17/2023 to file brief. Service: 03/29/2023 by email. [913182] [23-1334] [William Jay] [Entered: 03/29/2023 07:27 PM] (8) |
| Feb 16, 2023 | 8 | Certified list received. Service: 02/14/2023 by email. Refer to Fed. Cir. R. 31 for calculating brief deadlines from service of the certified list. [904626] [KMH] [Entered: 02/16/2023 09:42 AM] (0) |
| Jan 19, 2023 | 7 | Docketing Statement for the Appellants Novartis Pharma AG, Novartis Pharmaceuticals Corporation and Novartis Technology LLC. Service: 01/19/2023 by email. [898221] [23-1334] [William Jay] [Entered: 01/19/2023 08:24 PM] (2) |
| Jan 19, 2023 | 6 | Certificate of Interest for Appellants Novartis Pharma AG, Novartis Pharmaceuticals Corporation and Novartis Technology LLC. Service: 01/19/2023 by email. [898220] [23-1334] [William Jay] [Entered: 01/19/2023 08:23 PM] (3) |
| Jan 19, 2023 | 5 | Entry of Appearance for William M. Jay; William James; Elizabeth Holland, Gerard J. Cedrone as counsel for Appellants Novartis Pharma AG, Novartis Pharmaceuticals Corporation and Novartis Technology LLC. Service: 01/19/2023 by email. [898219] [23-1334] [William Jay] [Entered: 01/19/2023 08:19 PM] (2) |
| Jan 19, 2023 | 4 | Docketing Statement for the Appellee Regeneron Pharmaceuticals, Inc.. Service: 01/19/2023 by email. [898144] [23-1334] [Anish Desai] [Entered: 01/19/2023 04:26 PM] (2) |
| Jan 19, 2023 | 3 | Certificate of Interest for Appellee Regeneron Pharmaceuticals, Inc.. Service: 01/19/2023 by email. [898141] [23-1334] [Anish Desai] [Entered: 01/19/2023 04:25 PM] (3) |
| Jan 19, 2023 | 2 | Entry of Appearance for Anish R. Desai; Elizabeth S. Weiswasser; Adam B. Banks; Christopher Pepe; Priyata Patel as counsel for Appellee Regeneron Pharmaceuticals, Inc.. Service: 01/19/2023 by email. [898140] [23-1334] [Anish Desai] [Entered: 01/19/2023 04:24 PM] (2) |
| Jan 5, 2023 | 1 | Appeal docketed. Received: 12/23/2022. [894837] Entry of Appearance due 01/19/2023. Certificate of Interest is due on 01/19/2023. Docketing Statement due 01/19/2023. Certified List due on 02/14/2023. [KMH] [Entered: 01/05/2023 11:54 AM] (0) |
